Tag Archives: Drug Pricing

Report: CMS’ Proposed Rule to Encourage Value-Based Payment Arrangements with Drug Manufacturers

Doctor using laptop for telehealth visit to discuss medication with patient.

The Centers for Medicare and Medicaid Services (CMS) is updating its rules to encourage states, payers, and Medicare programs to enter value-based payment arrangements (VPA) with drug manufacturers to help reduce drug costs. What does this mean for Medicare providers and beneficiaries?

The Rundown | Week of 7.29.2019

Are health systems underinvesting in primary care? Do wearables improve health outcomes? What is in the Senate’s drug pricing legislation? Find the answers to these questions and more in The Rundown!

The Rundown | Week of 7.8.2019

What happened to Trump’s drug pricing proposal? Does downside risk help accountable care organizations? Can the common cold cure some cancers? Find the answers to these questions and more in The Rundown!

The Rundown | Week of 5.13.2019

Will listing drug prices rein in costs? Is meditation harmful? How does President Trump plan to combat surprise billing? Find the answers to these questions and more in The Rundown!